• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD. BD PEGASUS PLUS¿ CLOSED NEEDLE PROTECTION IV CATHETER SYSTEM; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD. BD PEGASUS PLUS¿ CLOSED NEEDLE PROTECTION IV CATHETER SYSTEM; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383745
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Fever (1858); Inflammation (1932)
Event Date 06/28/2023
Event Type  Injury  
Event Description
It was reported that after use with bd pegasus plus¿ closed needle protection iv catheter system patient experienced bloodstream infection.Anti-infection treatment was also given after removal, and the patient's condition gradually eased.This is 5th of 5 patients reported.The following information was provided by the initial reporter, translated from chinese to english: the head nurse of the gynecology department reported that after the product was used by patients, bloodstream infections occurred and the same bacteria were detected and cultured.Due to the high frequency of occurrence, the hospital suspected that the product was contaminated by bacteria, and hoped that bd company could help it detect whether there was bacterial contamination in the product.Additional information received from the sales representative: this batch of bloodstream infection reports involves 5 patients.In view of the sudden outbreak of many people, the hospital attaches great importance to it 1.The reported patients all had redness, swelling, heat pain, fever all over the body, and some patients had chills; 2.Most bloodstream infections occur within 48 hours, sometimes within 72 hours, or within 24 hours after extubation.3.After the patient developed redness, swelling, heat, pain and fever, the indwelling needle was removed, and the tip of the catheter was cut off for culture.Anti-infection treatment was also given after removal, and the patient's condition gradually eased; 4.The indwelling needle was fully packaged before use, and the puncturer was trained and experienced, but i was not present at the time of puncture, so it is impossible to know whether the aseptic operation is strict, but there has been no bloodstream infection of the indwelling needle in this department before.Received an additional update from the sales representative: 1.Yes, catheter tip positive, same bacteria as blood culture; 2.At present, other links have been ruled out, so the indwelling needle is highly suspected.
 
Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that after use with bd pegasus plus¿ closed needle protection iv catheter system patient experienced bloodstream infection.Anti-infection treatment was also given after removal, and the patient's condition gradually eased.This is 5th of 5 patients reported.The following information was provided by the initial reporter, translated from chinese to english: the head nurse of the gynecology department reported that after the product was used by patients, bloodstream infections occurred and the same bacteria were detected and cultured.Due to the high frequency of occurrence, the hospital suspected that the product was contaminated by bacteria, and hoped that bd company could help it detect whether there was bacterial contamination in the product.Additional information received from the sales representative: this batch of bloodstream infection reports involves 5 patients.In view of the sudden outbreak of many people, the hospital attaches great importance to it 1.The reported patients all had redness, swelling, heat pain, fever all over the body, and some patients had chills; 2.Most bloodstream infections occur within 48 hours, sometimes within 72 hours, or within 24 hours after extubation.3.After the patient developed redness, swelling, heat, pain and fever, the indwelling needle was removed, and the tip of the catheter was cut off for culture.Anti-infection treatment was also given after removal, and the patient's condition gradually eased; 4.The indwelling needle was fully packaged before use, and the puncturer was trained and experienced, but i was not present at the time of puncture, so it is impossible to know whether the aseptic operation is strict, but there has been no bloodstream infection of the indwelling needle in this department before.Received an additional update from the sales representative: 1.Yes, catheter tip positive, same bacteria as blood culture; 2.At present, other links have been ruled out, so the indwelling needle is highly suspected.
 
Manufacturer Narrative
H.6.Investigation summary: in response to the event reported a device history review was conducted for lot number 3048294.Our records show that this is the only instance of this issue occurring in this production batch.According to the sampling plan applied for product performance, this lot was accepted and released without defects being noted during the final assembly or visual inspections.Additionally, used samples cannot be tested for biological contamination that occurred prior to the opening of the package.This lot was treated and received a certificate of conformance for sterility.Unfortunately, without the ability to investigate the affected unit our quality engineers were unable to determine the root cause for this complaint.Bd will continue to monitor this issue.See h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PEGASUS PLUS¿ CLOSED NEEDLE PROTECTION IV CATHETER SYSTEM
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD.
9 rui pu road export zone b
suzhou
CH 
Manufacturer (Section G)
BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD.
9 rui pu road export zone b
suzhou
CH  
Manufacturer Contact
jennifer suh
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key17358101
MDR Text Key319377820
Report Number3006948883-2023-00077
Device Sequence Number1
Product Code FOZ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 08/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number383745
Device Lot Number3048294
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/28/2023
Initial Date FDA Received07/20/2023
Supplement Dates Manufacturer Received08/04/2023
Supplement Dates FDA Received08/22/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/17/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-